Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study.
作者信息
Liu Chen-Xi, Zhang Yun-Yu, Yang Qiu-Shi, Shen Shu-Hong, Chen Jing, Tang Yan-Jing, Chen Chang-Cheng, Wang Zhuo, Li Bi-Ru, Qian Juan, Wang Ying, Hu Wen-Ting, Ning Bo-Tao
机构信息
Department of Pediatric Hematology and Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Department of Pediatric Intensive Care Unit, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
出版信息
World J Emerg Med. 2022;13(4):313-321. doi: 10.5847/wjem.j.1920-8642.2022.062.
Abstract
摘要
相似文献
1
Asparaginase-associated pancreatitis in chemotherapy-treated pediatric patients: a five-year retrospective study.
World J Emerg Med. 2022;13(4):313-321. doi: 10.5847/wjem.j.1920-8642.2022.062.
2
Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.
Front Oncol. 2020 Oct 28;10:538779. doi: 10.3389/fonc.2020.538779. eCollection 2020.
3
Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
J Oncol Pharm Pract. 2018 Jun;24(4):299-308. doi: 10.1177/1078155217701291. Epub 2017 Mar 29.
4
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Pediatr Blood Cancer. 2005 Jan;44(1):95-7. doi: 10.1002/pbc.20187.
5
Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
Cancer. 2008 Sep 15;113(6):1362-9. doi: 10.1002/cncr.23716.
6
Predicting asparaginase-associated pancreatitis.
Pediatr Blood Cancer. 2007 Oct 15;49(5):634-9. doi: 10.1002/pbc.21037.
7
[Severe acute pancreatitis in children receiving asparaginase: multicenter retrospective study].
Arch Pediatr. 2005 Jan;12(1):34-41. doi: 10.1016/j.arcped.2004.07.020.
8
Retraction: Peg-Asparaginase-Associated Pancreatitis in Chemotherapy-Treated Pediatric Patients: A 5-Year Retrospective Study.
Front Oncol. 2021 Jun 3;11:709636. doi: 10.3389/fonc.2021.709636. eCollection 2021.
9
Successful Management of l-Asparaginase-Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase-Associated Pancreatitis?
Clin Ther. 2020 Apr;42(4):e82-e86. doi: 10.1016/j.clinthera.2020.02.015. Epub 2020 Mar 14.
10
Successful use of octreotide as a chemoprotectant for prevention of PEG-asparaginase-induced pancreatitis.
Pharmacotherapy. 2014 Aug;34(8):e149-51. doi: 10.1002/phar.1460.
引用本文的文献
1
Risk factors and outcome of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia.
Front Oncol. 2025 Jun 26;15:1606261. doi: 10.3389/fonc.2025.1606261. eCollection 2025.
2
Asparaginase-associated Pancreatitis Complicated by Pancreatic Fluid Collection Treated with Endoscopic Cistogastrostomy in Pediatric Acute Lymphoblastic Leukemia: A Case Report and Systematic Review of the Literature.
Clin Hematol Int. 2023 Dec 20;5(4):51-61. doi: 10.46989/001c.90958. eCollection 2023.
本文引用的文献
1
Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management.
J Oncol Pharm Pract. 2020 Jan;26(1):74-92. doi: 10.1177/1078155219838316. Epub 2019 Mar 27.
2
Safety profile of a single pegylated asparaginase (PEG-ASP) dose in remission induction for acute lymphoblastic leukemia (ALL).
Neoplasma. 2018 Nov 15;65(6):993-997. doi: 10.4149/neo_2018_180214N121. Epub 2018 Jun 17.
3
Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study.
Lancet Oncol. 2017 Sep;18(9):1238-1248. doi: 10.1016/S1470-2045(17)30424-2. Epub 2017 Jul 20.
4
Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review.
J Clin Gastroenterol. 2017 Nov/Dec;51(10):907-913. doi: 10.1097/MCG.0000000000000827.
5
Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol.
Leukemia. 2017 Feb;31(2):325-332. doi: 10.1038/leu.2016.203. Epub 2016 Jul 25.
6
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.
J Pediatr Hematol Oncol. 2016 Aug;38(6):409-17. doi: 10.1097/MPH.0000000000000589.
7
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus.
Lancet Oncol. 2016 Jun;17(6):e231-e239. doi: 10.1016/S1470-2045(16)30035-3.
8
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.
J Clin Oncol. 2016 Jun 20;34(18):2133-40. doi: 10.1200/JCO.2015.64.5812. Epub 2016 Apr 25.
9
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Lancet Oncol. 2015 Dec;16(16):1677-90. doi: 10.1016/S1470-2045(15)00363-0. Epub 2015 Nov 6.
10
Serial Ultrasound Monitoring for Early Recognition of Asparaginase Associated Pancreatitis in Children With Acute Lymphoblastic Leukemia.
Pediatr Hematol Oncol. 2015;32(7):474-81. doi: 10.3109/08880018.2015.1055868. Epub 2015 Aug 13.
Zotero 插件